New hope for rare nerve cancer: experimental drug shows promise in early trial
NCT ID NCT04917042
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This study tests a drug called tazemetostat in 10 people with a rare type of nerve tumor (MPNST) that has returned or spread. The goal is to see if the drug can shrink tumors or stop them from growing. Participants take the drug by mouth and are monitored with scans to measure response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL NERVE SHEATH TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.